Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32887877.
- Also identified by DOI 10.1038/s41467-020-18204-2 and PMC identifier 7473865.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
CD4<sup>+</sup> helper T cells contribute important functions to the immune response during pathogen infection and tumor formation by recognizing antigenic peptides presented by class II major histocompatibility complexes (MHC-II). While many computational algorithms for predicting peptide binding to MHC-II proteins have been reported, their performance varies greatly. Here we present a yeast-display-based platform that allows the identification of over an order of magnitude more unique MHC-II binders than comparable approaches. These peptides contain previously identified motifs, but also reveal new motifs that are validated by in vitro binding assays. Training of prediction algorithms with yeast-display library data improves the prediction of peptide-binding affinity and the identification of pathogen-associated and tumor-associated peptides. In summary, our yeast-display-based platform yields high-quality MHC-II-binding peptide datasets that can be used to improve the accuracy of MHC-II binding prediction algorithms, and potentially enhance our understanding of CD4<sup>+</sup> T cell recognition.
Medical subject headings
- Epitopes, T-Lymphocyte
- Oligopeptides